Cargando…
Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis
BACKGROUND: With the continuous development of cardiac interventional medicine, the incidence of contrast-induced nephropathy (CIN) is increasing every year, which is a serious threat to people's physical and mental health. Trimetazidine (TMZ) is a type of anti-ischemic drug developed in recent...
Autores principales: | Ye, Ziliang, Lu, Haili, Su, Qiang, Guo, Wenqin, Dai, Weiran, Li, Hongqing, Yang, Huafeng, Li, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340434/ https://www.ncbi.nlm.nih.gov/pubmed/28248861 http://dx.doi.org/10.1097/MD.0000000000006059 |
Ejemplares similares
-
The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2016) -
Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency
por: Ye, Ziliang, et al.
Publicado: (2017) -
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017) -
Safe Contrast Volumes for Preventing Contrast-Induced Nephropathy in Elderly Patients With Relatively Normal Renal Function During Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2015) -
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)